Intellia vs Tessera Therapeutics
Intellia Therapeutics develops one-time CRISPR gene-editing treatments delivered into the body in lipid nanoparticles, led by lonvo-z for hereditary angioedema and nex-z for transthyretin amyloidosis.
Gene Writing platform using engineered mobile genetic elements to write everything from single bases to whole genes.
Start your free week.
7 days of everything:
The Briefing, free: frontier tech in under 10 minutes, every morning, read or listened to. Yours to keep after the week.
30 sectors
One dashboard each, refreshed every day.
1,200+ companies
Funding, leadership, hiring, competitors.
Jobs board
Roles at companies LinkedIn never shows.
Video
What's hyped on 1,200+ official company channels.
Investors & exits
Who funds the frontier, and who bought what.
Frontline
The day's developments in every sector, scored.